SA and India press for IP waiver for Covid-19 drugs at WTO
Opponents, including the EU, US and Switzerland, show little sign of budging
19 January 2021 - 21:21
Geneva — SA and India argued in favour of a waiver of intellectual property (IP) rights on Covid-19 drugs and vaccines at a closed-door meeting of the World Trade Organisation (WTO) on Tuesday but opponents showed little sign of budging, trade sources said.
Proponents of the temporary waiver as the pandemic continues to rage say that IP rules are hindering the urgent scale-up of Covid-19 vaccine production amid growing criticism of the inequitable distribution of shots...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.